Concepedia

Zhengnan Shen

ZS

Statistics

Publications

10

Citations

461

H-Index

10

Active since

2019

Affiliations

University of Illinois Chicago(Current)

University of Arizona

Illinois College

Zhengnan Shen is an author at University of Illinois Chicago specializing in drug discovery, medicine, and pharmacology.

ORCID

Publications per year

2019–2024

10

Publications

10

Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity

Zhengnan Shen, Kiira Ratia, Laura Cooper et al. · Journal of Medicinal Chemistry · 2021 · 211 citations · Full text

, , +16

XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer

Daniel R. Principe, Rui Xiong, Yangfeng Li et al. · Proceedings of the National Academy of Sciences · 2022 · 43 citations · Full text

, , +17

Design and Synthesis of Basic Selective Estrogen Receptor Degraders for Endocrine Therapy Resistant Breast Cancer

Yunlong Lu, Lauren M. Gutgesell, Rui Xiong et al. · Journal of Medicinal Chemistry · 2019 · 40 citations · Full text

, , +16

Potent, Novel SARS-CoV-2 PLpro Inhibitors Block Viral Replication in Monkey and Human Cell Cultures

Zhengnan Shen, Kiira Ratia, Laura Cooper et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 40 citations · Full text

, , +17

Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib

Yangfeng Li, Jiong Zhao, Lauren M. Gutgesell et al. · Journal of Medicinal Chemistry · 2020 · 36 citations · Full text

, , +17

1–5 of 10